KURN Share Price Performance
CHF 30.18
2.28 (8.17%)
Price CHF 30.18
Share PriceCHF 30.18
Kuros Biosciences AG's (VTX:KURN) Sole Analyst Just Made A Notable Upgrade To Their Forecasts
Oct 18
Kuros Biosciences AG Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 8 Fair Values set on narratives written by author
KURN Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Kuros Biosciences AG Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Mar 10, 2026
- -0.15
- 88.70%
- -5.71%
- 0%
About KURN
- Founded
- 2016
- Employees
- 158
- CEO
- WebsiteView website
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bone grafts that mimic the porous and trabecular structure of cancellous bone, as well as checkmate licensing. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.
